Filing Details
- Accession Number:
- 0001179110-12-001711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-03 12:40:55
- Reporting Period:
- 2012-02-01
- Filing Date:
- 2012-02-03
- Accepted Time:
- 2012-02-03 12:40:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134655 | Ansbert Gadicke | C/O Verastem, Inc. 215 First Street, Suite 440 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-01 | 1,142,857 | $0.00 | 1,142,857 | No | 4 | C | Indirect | By MPM Bioventures V, LP |
| Common Stock | Acquisiton | 2012-02-01 | 714,286 | $0.00 | 1,857,143 | No | 4 | C | Indirect | By MPM Bioventures V, LP |
| Common Stock | Acquisiton | 2012-02-01 | 76,190 | $0.00 | 1,933,333 | No | 4 | C | Indirect | By MPM Bioventures V, LP |
| Common Stock | Acquisiton | 2012-02-01 | 96,260 | $10.00 | 2,029,593 | No | 4 | P | Indirect | By MPM Bioventures V, LP |
| Common Stock | Acquisiton | 2012-02-01 | 3,740 | $10.00 | 3,740 | No | 4 | P | Indirect | By MPM Asset Management Investors BV5 LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By MPM Bioventures V, LP |
| No | 4 | C | Indirect | By MPM Bioventures V, LP |
| No | 4 | C | Indirect | By MPM Bioventures V, LP |
| No | 4 | P | Indirect | By MPM Bioventures V, LP |
| No | 4 | P | Indirect | By MPM Asset Management Investors BV5 LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2012-02-01 | 4,000,000 | $0.00 | 1,142,857 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2012-02-01 | 2,500,000 | $0.00 | 714,286 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2012-02-01 | 266,666 | $0.00 | 76,190 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of preferred stock automatically converted into approximately 0.29 shares of common stock upon the closing of the issuer's initial public offering without payment of consideration.
- Not applicable.
- The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
